MARKET

OPHLF

OPHLF

Ono Pharmaceutic
OTCPK
14.61
NaN%
Opening 09:30 07/28 EDT
OPEN
--
PREV CLOSE
14.90
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
41.67
52 WEEK LOW
14.55
MARKET CAP
6.87B
P/E (TTM)
15.62
1D
5D
1M
3M
1Y
5Y
1D
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
TipRanks · 07/20 16:31
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
TipRanks · 07/15 16:30
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
TipRanks · 07/08 16:30
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
TipRanks · 07/08 16:30
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
TipRanks · 06/26 16:31
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
TipRanks · 06/18 16:31
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
TipRanks · 06/05 16:31
Analysts Are Neutral on These Healthcare Stocks: CSL (CMXHF), ONO Pharmaceutical Co (OPHLF)
TipRanks · 05/31 12:20
More
About OPHLF
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.

Webull offers Ono Pharmaceutical Co Ltd stock information, including OTCPK: OPHLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPHLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPHLF stock methods without spending real money on the virtual paper trading platform.